Feb 28, 2024 06:30AM
Jan 8, 2024 06:45AM
Jan 3, 2024 09:00AM
Oct 6, 2023 06:26AM
Jan 3, 2023 02:00PM
Dec 6, 2022 10:36AM
Jan 21, 2022 11:43AM Form SC 13G G1 Therapeutics, Inc. Filed by: JPMORGAN CHASE & CO
Jan 4, 2022 09:15AM
Nov 4, 2021 07:10AM
Sep 30, 2021 05:03AM
Feb 16, 2021 03:13PM
Jan 5, 2021 07:00AM
Jan 7, 2020 07:00AM
Aug 8, 2019 08:36AM UPDATE: JPMorgan Upgrades G1 Therapeutics (GTHX) to Overweight Ahead of Catalysts
Jan 23, 2019 05:11AM
Dec 27, 2018 07:00AM
Dec 27, 2018 07:00AM
Sep 21, 2018 04:05PM
Sep 21, 2018 04:05PM
Sep 19, 2018 05:49AM
Sep 18, 2018 09:37PM G1 Therapeutics Announces Pricing of Offering of Common Stock
Sep 18, 2018 09:37PM
Sep 17, 2018 04:03PM
Sep 17, 2018 04:01PM
Sep 17, 2018 04:01PM
Mar 12, 2018 04:05PM
Mar 12, 2018 04:05PM
Mar 8, 2018 05:16AM G1 Therapeutics (GTHX) Prices 3.4M Shares at $29.50
Mar 7, 2018 09:54PM
Mar 7, 2018 09:54PM
Mar 5, 2018 04:20PM
Mar 5, 2018 04:18PM
Mar 5, 2018 04:18PM
Feb 22, 2018 07:05AM
Jan 2, 2018 07:00AM G1 Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference
Jan 2, 2018 07:00AM
Jun 12, 2017 12:47AM
May 23, 2017 08:00AM
May 17, 2017 10:52AM
May 17, 2017 05:52AM
May 16, 2017 07:25PM
May 8, 2017 09:02AM G1 Therapeutics Announces Launch of Initial Public Offering

276,561 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All